Help For Ragweed Allergy

Thursday, 17 Apr 2014 04:02 PM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink
The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis.

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Ragwitek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Hard-to-Abuse Painkiller

Thursday, 20 Nov 2014 16:36 PM

Federal health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering a . . .

New Help for Multiple Sclerosis

Saturday, 15 Nov 2014 18:39 PM

The Food and Drug Administration has approved Lemtrada, a treatment for relapsing multiple sclerosis made by the drugmak . . .

2-in-1 Diabetes Pill

Thursday, 30 Oct 2014 08:19 AM

A new two-in-one diabetes pill from AstraZeneca has been approved by U.S. regulators, the British drugmaker said on Thur . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved